European Journal of Gastroenterology & Hepatology · 2006 · 35 citations · 6 references
PharmacyPharmacotherapyCardiovascular PharmacotherapyGastrointestinal PharmacotherapyPain ManagementVasoactive Drug TherapyVasoactive MedicationsVasodilator TherapyAnal UlcerationDrug-induced Oral UlcerationDrug-induced Oral UlcersHistological StructureManagement Of High-risk PatientsNicorandil Therapy
Nicorandil is a vasodilator used to control severe angina. It has been associated with oral and anal ulceration that resolves upon withdrawal of the drug. We report a series of four patients, all of whom were receiving nicorandil therapy and developed nonspecific para-stomal ulcerations of similar clinical and histological appearance. All ulcers healed on withdrawal of nicorandil with no relapse. To the best of our knowledge, nicorandil-associated para-stomal ulcers have not been reported before. It is imperative to be aware of this association to prevent the persistence of these extremely painful ulcerations, and to avoid unnecessary and inappropriate interventions with substantial morbidity in a group of high-risk patients.
6
Nicorandil associated anal ulceration
Angus Watson, Ous Al Ozairi, Andy Fraser et al. · The Lancet · 2002 · 127 citations
Nicorandil may be associated with gastrointestinal ulceration
Mohaned Egred, Mohammed Andron, W.L. Morrison · BMJ · 2006 · 66 citations · Full text
Nicorandil associated anal ulceration
Angus Watson, Stuart Suttie, A. Fraser et al. · Colorectal Disease · 2004 · 41 citations